ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,849.72
-1.76%
US Tech 100
19,908.80
0.13%
다우존스 지수
43,191.24
-1.48%
Bitcoin
83,908.61
-2.53%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Abionyx Pharma Sa (0RAG) 시세

Abionyx Pharma Sa

Abionyx Pharma Sa (0RAG)

LSE
2.03
0.00
( 0.00% )
업데이트: 09:00:00
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
2.03
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
2.03 52주 범위 2.03
market_cap
65.892M
전일 종가
2.03
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
204
발행 주식
32,459,000
배당수익률
-
주가수익률
-11.81
주당순이익(EPS)
-0.11
매출
4.74M
순이익
-3.52M

Abionyx Pharma Sa 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.abionyx.com
본부
Balma, Haute-garonne, Fra
설립됨
-
Abionyx Pharma Sa is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker 0RAG. The last closing price for Abionyx Pharma was 2.03 €. Over the last year, Abionyx Pharma shares have traded in a share price range of 2.03 € to 2.03 €.

Abionyx Pharma currently has 32,459,000 shares in issue. The market capitalisation of Abionyx Pharma is 65.89 € million. Abionyx Pharma has a price to earnings ratio (PE ratio) of -11.81.

0RAG 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1002.032.032.033142.03DE
4002.032.032.031312.03DE
12002.032.032.032042.03DE
26002.032.032.031412.03DE
52002.032.032.03772.03DE
156002.032.032.038272.03DE
260002.032.032.038722.03DE

0RAG - Frequently Asked Questions (FAQ)

What is the current Abionyx Pharma share price?
The current share price of Abionyx Pharma is 2.03 €
How many Abionyx Pharma shares are in issue?
Abionyx Pharma has 32,459,000 shares in issue
What is the market cap of Abionyx Pharma?
The market capitalisation of Abionyx Pharma is EUR 65.89M
What is the 1 year trading range for Abionyx Pharma share price?
Abionyx Pharma has traded in the range of 2.03 € to 2.03 € during the past year
What is the PE ratio of Abionyx Pharma?
The price to earnings ratio of Abionyx Pharma is -11.81
What is the cash to sales ratio of Abionyx Pharma?
The cash to sales ratio of Abionyx Pharma is 8.77
What is the reporting currency for Abionyx Pharma?
Abionyx Pharma reports financial results in EUR
What is the latest annual turnover for Abionyx Pharma?
The latest annual turnover of Abionyx Pharma is EUR 4.74M
What is the latest annual profit for Abionyx Pharma?
The latest annual profit of Abionyx Pharma is EUR -3.52M
What is the registered address of Abionyx Pharma?
The registered address for Abionyx Pharma is 33-43 AVENUE GEORGES POMPIDOU, BATIMENT D, BALMA, HAUTE-GARONNE, 31130
What is the Abionyx Pharma website address?
The website address for Abionyx Pharma is www.abionyx.com
Which industry sector does Abionyx Pharma operate in?
Abionyx Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
WSGWestminster Group Plc
1.40p
(27.27%)
2.57M
WHRWarehouse Reit Plc
98.50p
(16.16%)
5.56M
MET1Metals One Plc
0.575p
(15.00%)
1.85M
ZENZenith Energy Ltd.
7.75p
(14.81%)
2.18M
CORCorpus Resources Plc
0.016p
(14.29%)
192.78M
SAVESavannah Energy Plc
9.30p
(-64.57%)
160.81M
VELAVela Technologies Plc
0.003p
(-40.00%)
888.11M
TIGTeam Internet Group Plc
60.00p
(-39.15%)
3.34M
ALBAAlba Mineral Resources
0.014p
(-24.32%)
84.19M
SYMESupply@me Capital Plc
0.003p
(-23.08%)
19.14M
VELAVela Technologies Plc
0.003p
(-40.00%)
888.11M
TRPTower Resources Plc
0.023p
(-2.13%)
203.78M
CORCorpus Resources Plc
0.016p
(14.29%)
192.78M
SAVESavannah Energy Plc
9.30p
(-64.57%)
160.81M
MSMNMosman Oil And Gas Limited
0.029p
(-4.92%)
154.3M

토론

전체 피드 보기
Jake731 Jake731 1 분 전
Good morning all.




TPTW……!!!!!!!!
TPTW
Saving Grace Saving Grace 1 분 전
Good update! Bitcoin et al are not currencies. Will soon be phased out.

America is back on the Gold standard. Address to both houses of congress today.
BTCUSD
bgoat bgoat 2 분 전
I guess your gonna sell again 😅, no audit coming, I need some cheapies today!! 🤑
BMXI
NASDAQ2020 NASDAQ2020 2 분 전
Bidding war will ensue !

It Just Got Real !

ELTP
ELTP
plugger plugger 2 분 전
New King James Version-----Habakkuk 2: 18-19

“What profit is the image, that its maker should carve it,
The molded image, a teacher of lies,
That the maker of its mold should trust in it,
To make mute idols?
Woe to him who says to wood, ‘Awake!’
To
stocktowatch stocktowatch 3 분 전
$IVDN News! Innovative Designs, Inc. Reaches Profitability for First Time by Reporting of Record Sales Results in Fiscal Year 2024, Delivering Almost 300% Revenue Increase vs. Previous Year https://finance.yahoo.com/news/innovative-designs-inc-reaches-profitability-134500785.html
IVDN
100lbStriper 100lbStriper 3 분 전
SilviaJ $NLST Patent 339 Sur Reply filed today. Ready for court calendaring:

Netlist’s ’339 patent uses a plurality of “buffers” whereby the data paths from the controller to memory devices can be enabled as needed.

The challenged claims require: that the buffer da
NLST
LTR LTR 4 분 전
Wrong. The shares that are being bought are NOT holding up the stock price while the shares you lend out are used to damage the stock price and our long term investment by evil people. You simply can’t claim neutrality here.
NWBO
TheRealMrPirate TheRealMrPirate 5 분 전
Just imagine if you owned shares in LCY Chemical.
Oh wait, you don't.
They're not a publicly traded company 🥴
glenn1919 glenn1919 6 분 전
TSLZ.......................SYTA..............................https://stockcharts.com/h-sc/ui?s=TSLZ&p=W&yr=1&mn=3&dy=0&id=p96837884856
SYTA TSLZ
Chiron Chiron 6 분 전
With this float it should be .003 +
BLLB
hedge_fun hedge_fun 6 분 전
Their focus is the 10 year. It’s going……..

as planned.

And they say, don’t fight the fed.
SMCI
Omar8 Omar8 7 분 전
DP,




From a post by ANT....."Jon Jon. 1st I do not have an attorney handling this I'm handling it myself. An attorney would have cost 30-40,000 already. I am familiar with the Faro's attorney a very large multi state firm where junior attorneys cost 4-500 and se
NNLX
nanobuyer nanobuyer 9 분 전
Yesterday and today, my attempts to access groen-tech.com result in Norton flagging the site as a potential trojan-horse. While that's not necessarily the case, it does indicate another change to the website—by whom and why? Just curious.
glenn1919 glenn1919 9 분 전
tslz................................................................................................p/m
TSLZ
Stino2 Stino2 10 분 전
To bad for the board of company that the stock is sooooo low 🤮
TNXP
gedi8 gedi8 12 분 전
We will see my friend. His first month in office has really hurt the market. I hope you are right

No need for personal attacks. I states an opinion. If you disagree that’s okay. By the way I know what’s going on. I’m in my mid 70s and served this country. I’ve seen a lot in my ye
NXPL
WooptdooU WooptdooU 13 분 전
Why don't these GRIFTERS use their OWN money and buy at the market.... they are NOT AFRAID of the helplessly hopeful pennylongs.
LWLG
louieforpar louieforpar 13 분 전
Less than four one way or another. 


glenn1919 glenn1919 14 분 전
INLF....................................................................................p/m
INLF
uranium-pinto-beans uranium-pinto-beans 14 분 전
OKTA
Okta upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Rudy Kessinger upgraded Okta to Buy from Neutral with a price target of $125, up from $90. The company reported "very strong" Q4 results and meaningfully raised its fiscal 2026 guidance, the analyst tells inve
OKTA
WooptdooU WooptdooU 15 분 전
These scummy insiders have done NOTHING but TAKE...they must believe the helplessly hopeful pennylongs are harmless to them.
LWLG
uranium-pinto-beans uranium-pinto-beans 16 분 전
mmmm


https://www.bloomberg.com/news/articles/2025-03-03/citi-copy-paste-error-almost-sent-6-billion-to-wealth-account

최근 히스토리

LSE
0RAG
Abionyx Pharma
NYSE
NWG
NatWest
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지